Beacon Investment Advisory Services’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$20.6M Sell
17,158
-860
-5% -$879K 0.76% 38
2026
Q1
$16.6M Sell
18,018
-1,060
-6% -$1.07M 0.68% 44
2025
Q4
$20.5M Sell
19,078
-1,080
-5% -$1.03M 0.84% 36
2025
Q3
$15.4M Sell
20,158
-2,342
-10% -$1.74M 0.65% 45
2025
Q2
$17.5M Sell
22,500
-2,688
-11% -$2.09M 0.77% 42
2025
Q1
$20.8M Sell
25,188
-2,934
-10% -$2.44M 0.97% 35
2024
Q4
$21.7M Buy
28,122
+8,172
+41% +$6.77M 0.94% 40
2024
Q3
$17.7M Buy
19,950
+906
+5% +$815K 0.74% 46
2024
Q2
$17.2M Buy
19,044
+222
+1% +$178K 0.74% 45
2024
Q1
$14.6M Sell
18,822
-292
-2% -$208K 0.63% 51
2023
Q4
$11.1M Sell
19,114
-80
-0.4% -$46.7K 0.51% 58
2023
Q3
$10.3M Buy
19,194
+466
+2% +$240K 0.51% 56
2023
Q2
$8.78M Buy
18,728
+12,978
+226% +$5.44M 0.4% 63
2023
Q1
$1.97M Buy
5,750
+2,167
+60% +$731K 0.1% 125
2022
Q4
$1.31M Sell
3,583
-19
-0.5% -$6.74K 0.07% 135
2022
Q3
$1.17M Sell
3,602
-226
-6% -$71.6K 0.06% 139
2022
Q2
$1.24M Sell
3,828
-281
-7% -$84.3K 0.06% 145
2022
Q1
$1.18M Buy
4,109
+596
+17% +$153K 0.05% 150
2021
Q4
$970K Sell
3,513
-441
-11% -$112K 0.04% 170
2021
Q3
$914K Sell
3,954
-65
-2% -$16K 0.04% 172
2021
Q2
$922K Sell
4,019
-528
-12% -$106K 0.04% 173
2021
Q1
$849K Sell
4,547
-944
-17% -$185K 0.04% 168
2020
Q4
$927K Buy
5,491
+3,691
+205% +$551K 0.04% 153
2020
Q3
$266K Buy
1,800
+165
+10% +$25.5K 0.01% 211
2020
Q2
$268K Sell
1,635
-1,191
-42% -$183K 0.02% 211
2020
Q1
$392K Sell
2,826
-80
-3% -$11K 0.03% 173
2019
Q4
$382K Sell
2,906
-123
-4% -$14.3K 0.02% 203
2019
Q3
$339K Sell
3,029
-30
-1% -$3.34K 0.03% 186
2019
Q2
$339K Sell
3,059
-370
-11% -$43.6K 0.04% 180
2019
Q1
$445K Hold
3,429
0.05% 154
2018
Q4
$397K Sell
3,429
-362
-10% -$40.4K 0.04% 175
2018
Q3
$407K Hold
3,791
0.04% 175
2018
Q2
$323K Sell
3,791
-275
-7% -$22.6K 0.03% 207
2018
Q1
$315K Sell
4,066
-567
-12% -$45.6K 0.03% 208
2017
Q4
$391K Sell
4,633
-3,108
-40% -$264K 0.04% 167
2017
Q3
$662K Buy
7,741
+4,633
+149% +$380K 0.06% 162
2017
Q2
$256K Sell
3,108
-142
-4% -$11.6K 0.05% 96
2017
Q1
$273K Hold
3,250
0.05% 72
2016
Q4
$239K Buy
3,250
+10
+0.3% +$745 0.05% 67
2016
Q3
$260K Sell
3,240
-15
-0.5% -$1.2K 0.06% 62
2016
Q2
$256K Hold
3,255
0.06% 61
2016
Q1
$234K Sell
3,255
-6
-0.2% -$454 0.05% 57
2015
Q4
$275K Sell
3,261
-6
-0.2% -$498 0.05% 53
2015
Q3
$273K Sell
3,267
-106
-3% -$8.95K 0.05% 48
2015
Q2
$282K Buy
+3,373
New +$257K 0.04% 49

Other funds holding LLY

Beacon Investment Advisory Services's LLY Position: Q2 2026 in Review

Beacon Investment Advisory Services reduced its Eli Lilly (LLY) stake by 4.8% in Q2 2026, selling an estimated $879K and leaving 17,158 shares worth $20.6M. The position accounts for 0.76% of the portfolio, ranked #38.

Beacon Investment Advisory Services first reported a position in LLY in Q2 2015 and has held it in 45 quarters since. The position peaked at $21.7M in Q4 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Beacon Investment Advisory Services held 17,158 shares of Eli Lilly worth $20.6M as of Q2 2026.
  • Beacon Investment Advisory Services sold 860 Eli Lilly shares in Q2 2026, an estimated $879K.
  • Eli Lilly made up 0.76% of Beacon Investment Advisory Services's portfolio in Q2 2026, its #38 holding.
  • Beacon Investment Advisory Services first reported a position in Eli Lilly in Q2 2015 and has held it in 45 quarters since.
  • Beacon Investment Advisory Services's Eli Lilly position peaked at $21.7M in Q4 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.